Anti-DOC-1 Antibody

Manufactured by Antibodies.com, this affinity-purified polyclonal reagent is raised in rabbit against the DOC-1 protein (also known as CDK2AP1), making it a reliable research tool for laboratories studying cell-cycle regulation and CDK2-associated pathways. The antibody is supplied at a 50 µl volume with a working concentration of 1 mg/ml, and the immunogen is a synthetic peptide derived from the internal region of human DOC-1, ensuring recognition of endogenous DOC-1 levels. It is unconjugated and of the IgG isotype, allowing flexibility for downstream labeling or secondary-detection workflows. Validated applications include Western blot (WB) and ELISA, while species reactivity has been confirmed for human and mouse samples. The product is presented as a liquid formulation in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide, and it is purified by affinity-chromatography using the epitope-specific immunogen to maximize specificity. For optimal stability, the supplier recommends storage at -20 °C, under which conditions the antibody remains stable for up to one year. Researchers should note that this reagent is intended for research use only and is not validated for diagnostic or therapeutic applications. Combining robust validation, broad cross-species reactivity, and a well-defined polyclonal response to an internal DOC-1 epitope, this Antibodies.com offering is well suited to immunoblotting and ELISA-based investigations of DOC-1/CDK2AP1 expression in cell and tissue lysates.